 Treatment options have been limited.However Imatinib, as an inhibitor to the malfunctioning enzyme, can be effective.If imatinib does not work, patients with advanced chronic myelogenous leukemia can use nilotinib, dasatinib, bosutinib, ponatinib, or another inhibitor to the malfunction enzyme that causes the leukemia.